Inhibition of SRC-3 enhances sensitivity of human cancer cells to histone deacetylase inhibitors.
Biochem Biophys Res Commun
; 478(1): 227-233, 2016 09 09.
Article
in En
| MEDLINE
| ID: mdl-27425252
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Nuclear Receptor Coactivator 3
/
Histone Deacetylase Inhibitors
/
Antibiotics, Antineoplastic
/
Neoplasms, Experimental
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Biochem Biophys Res Commun
Year:
2016
Document type:
Article
Country of publication: